ATM and pancreatic neoplasm: The expression of ATM and TP53 was determined by IHC in 397 surgically resected pancreatic ductal adenocarcinoma patients and a second set of 159 resected pancreatic cancer patients and 21 patients receiving neoadjuvant systemic treatment (42).